Gad Gilad, PhD

Dr. Gad Gilad, the co-founder and CEO of Gilad&Gilad, LLC (www.ForNerveHealth.com), received his PhD in neurobiology and behavior from Cornell University. His research focus is the response of the nervous system to stress, neurotrauma and neurodegenerative diseases, and the development of new therapeutics. His collaboration with Varda H. Gilad while working at several academic centers, including the National Institutes of Health, Weizmann Institute of Science and Harvard University, resulted in more than 100 peer-reviewed scientific papers and several patents. One of their main discoveries is the neuroprotective properties of agmatine.

Previous Articles

A Nutraceutical for Neuropathies: Agmatine
March 1, 2018 (Vol. 36, Issue 03)
Trending
News / Profession
MAHA Launches Chiropractic Hub
MAHA Launches Chiropractic Hub

Building on a historic March 2026 meeting between Make America Healthy Again and chiropractic leadership, MAHA has announced the launch of the MAHA Chiropractic Hub, “a coordinated national partnership uniting MAHA Center, MAHA Action, and the chiropractic profession, including national associations, state organizations, practitioners, educators, researchers, and patient advocates. The Chiropractic Hub will advance federal policy, expand patient access, and build broad public support for chiropractic care across America.”

 |  Digital Exclusive
Dynamic Chiropractic Staff
Education & Seminars
Confronting the Threat to Chiropractic Education
Confronting the Threat to Chiropractic Education

The chiropractic profession is confronting one of the most significant federal regulatory threats it has faced in decades. A new U.S. Department of Education (ED) accountability framework – commonly referred to as the “Do No Harm” (DNH) regulation – could place many chiropractic programs at risk of losing access to federal financial aid (student loans), potentially reshaping the future of chiropractic education and workforce development across the United States.

 |  Digital Exclusive
Healthcare / Public Health
From Pain Scores to Performance Metrics
From Pain Scores to Performance Metrics

Pain has become the dominant language of musculoskeletal healthcare. Numeric pain-rating scales and symptom reports are routinely used as primary indicators of clinical success. But while pain reduction is meaningful, it is an incomplete and often misleading representation of recovery. This has real consequences for patient adherence, long-term outcomes, and how conservative care is perceived within the broader healthcare system.

Christopher Proulx, DC, PhD(ABD), CSCS